An interventional study of Remifentanil and ciprofol and esketamine 0.3mg/kg and ciprofol in Quality of Postoperative Recovery, sponsored by Subei People's Hospital of Jiangsu Province. Not yet recruiting at 1 site in China. Open to participants aged 60 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-09-27.
Sponsored by Subei People's Hospital of Jiangsu Province · Not applicable, Interventional, and Treatment
To explore the impact of esketamine combined with ciprofol on the quality of early postoperative recovery in elderly patients undergoing painless gastroscopy, as well as the effectiveness and safety of this regimen.
Subei People's Hospital of Jiangsu Province is the lead sponsor of 5 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Scheduled painless gastroscopy examination and treatment
Exclusion Criteria:
Participants with concurrent dysfunction of major organs.
Ciprofol group will be started with ciprofol 0.2-0.4 mg/kg.
Drug: Ciprofol
R group will be started with remifentanil 0.5ug/kg and ciprofol 0.2-0.4 mg/kg.
Drug: Remifentanil and ciprofol
E1 group will be started with esketamine 0.3mg/kg and ciprofol 0.2-0.4 mg/kg.
Drug: esketamine 0.3mg/kg and ciprofol
E2 group will be started with esketamine 0.5mg/kg and ciprofol 0.2-0.4 mg/kg.
Drug: esketamine 0.5mg/kg and ciprofol
R group will be started with remifentanil 0.5ug/kg and ciprofol 0.4 mg/kg.
Anesthesia induction was initiated by esketamine 0.3mg/kg, followed by ciprofol 0.2-0.4mg/kg.
Anesthesia induction was initiated by esketamine 0.5mg/kg, followed by ciprofol 0.2-0.4mg/kg.
Ciprofol group will be started with ciprofol 0.2-0.4 mg/kg.
postoperative day 1(POD1) Quality of Recovery(QoR)-15 questionnaire score
Quality of life will be evaluated using Quality of Recovery(QoR)-15 questionnaire score at postoperative day 1(minimum value : 0, maximum value : 150, the higher the score, the better the result)
Time frame: Baseline (30 min before surgery), postoperative day 1
postoperative day 3(POD3) Quality of Recovery(QoR)-15 questionnaire score
Quality of life will be evaluated using Quality of Recovery(QoR)-15 questionnaire score at postoperative day 3(minimum value : 0, maximum value : 150, the higher the score, the better the result)
Time frame: Postoperative day 3 and 7
Cognitive function assessment
A Mini-Mental State Examination (MMSE) is a set of 11 questions that doctors and other healthcare professionals commonly use to check for cognitive impairment (problems with thinking, communication, understanding and memory). MMSE has a maximum total score of 30, with higher scores manifesting a better cognitive performance.
Time frame: Baseline (30 min before surgery), postoperative day 1,3 and 7
Hospital anxiety and depression scale ( HADS ) score.
Postoperative anxiety and depression scores will be measured by the Hospital Anxiety and Depression Scale, on the morning(8-10 am) of postoperative days (PODs) 1,3 and 7 , a score of 8 points or higher will be diagnosed as depression or anxiety.
Time frame: Baseline (30 min before surgery), postoperative day 1,3 and 7
Dosage of ciprofol
Consumption of ciprofol during endoscopic examination
Time frame: During endoscopic examination
Heart rate (HR)
Throughout the procedure, the heart rate (HR) was continuously monitored.
Time frame: Baseline,during surgery and arrived at PACU (up to 30 minutes after surgery)
Pulse oxygen saturation (SpO2)
Throughout the procedure, the pulse oxygen saturation (SpO2) were continuously monitored.
Time frame: Baseline, during surgery and arrived at PACU (up to 30 minutes after surgery)
Mean blood pressure (MBP)
Throughout the procedure, the mean blood pressure (MBP) was measured at 1-minute intervals.
Time frame: Baseline, during surgery and arrived at PACU (up to 30 minutes after surgery)
Patient satisfaction levels
The patients express their satisfaction with procedures on a visual analogue score, ranging from 0 to 10, where 0 is the minimum and 10 is the maximum satisfaction level.
Time frame: 30 minutes at recovery room.
The incidence of all drug-related adverse events
All drug-related adverse events including bradycardia, hypotension, tachycardia, hypertension, arrhythmia, nystagmus, hypersalivation, euphoria, emergence agitation, hallucinations, dreaminess and nightmares during surgery or before discharge.etc.Patients will be followed up for 3 days consecutively(at 8-10am).
Time frame: Within 72hours after surgery
Plan to share: No
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Subei People's Hospital of Jiangsu Province